Metabolic and genetic disorders mimicking cerebral palsy

References

1. ↵
   1. Graham HK,
   2. Rosenbaum P,
   3. Paneth N,
   4. Dan B,
   5. Lin JP,
   6. Damiano DL,
   7. et al.

   (2016) Cerebral palsy. Nat Rev Dis Primers 2, 15082.
2. ↵
   1. Colver A,
   2. Fairhurst C,
   3. Pharoah PO

   (2014) Cerebral palsy. Lancet 383, 1240–1249.
3. ↵
   1. Leach EL,
   2. Shevell M,
   3. Bowden K,
   4. Stockler-Ipsiroglu S,
   5. van Karnebeek CD

   (2014) Treatable inborn errors of metabolism presenting as cerebral palsy mimics:systematic literature review. Orphanet J Rare Dis 9, 197.
4. ↵
   1. Zouvelou V,
   2. Yubero D,
   3. Apostolakopoulou L,
   4. Kokkinou E,
   5. Bilanakis M,
   6. Dalivigka Z,
   7. et al.

   (2019) The genetic etiology in cerebral palsy mimics:The results from a Greek tertiary care center. Eur J Paediatr Neurol 23, 427–437.
5. ↵
   1. Appleton RE,
   2. Gupta R

   (2018) Cerebral palsy:not always what it seems. Arch Dis Child.
6. ↵
   1. Pearson TS,
   2. Pons R,
   3. Ghaoui R,
   4. Sue CM

   (2019) Genetic Mimics of Cerebral Palsy. Mov Disord 34, 625–636.
7. 1. Segel R,
   2. Ben-Pazi H,
   3. Zeligson S,
   4. Fatal-Valevski A,
   5. Aran A,
   6. Gross-Tsur V,
   7. et al.

   (2015) Copy number variations in cryptogenic cerebral palsy. Neurology 84, 1660–1668.
8. 1. Takezawa Y,
   2. Kikuchi A,
   3. Haginoya K,
   4. Niihori T,
   5. Numata-Uematsu Y,
   6. Inui T,
   7. et al.

   (2018) Genomic analysis identifies masqueraders of full-term cerebral palsy. Ann Clin Transl Neurol 5, 538–551.
9. ↵
   1. McMichael G,
   2. Bainbridge MN,
   3. Haan E,
   4. Corbett M,
   5. Gardner A,
   6. Thompson S,
   7. et al.

   (2015) Whole-exome sequencing points to considerable genetic heterogeneity of cerebral palsy. Mol Psychiatry 20, 176–182.
10. 1. Carecchio M,
    2. Mencacci NE

    (2017) Emerging monogenic complex hyperkinetic disorders. Curr Neurol Neurosci Rep 17, 97.
11. ↵
    1. Matthews AM,
    2. Blydt-Hansen I,
    3. Al-Jabri B,
    4. Andersen J,
    5. Tarailo-Graovac M,
    6. Price M,
    7. et al.

    (2018) Atypical cerebral palsy:genomics analysis enables precision medicine. Genet Med.
12. ↵
    1. Lee RW,
    2. Poretti A,
    3. Cohen JS,
    4. Levey E,
    5. Gwynn H,
    6. Johnston MV,
    7. et al.

    (2014) A diagnostic approach for cerebral palsy in the genomic era. Neuromolecular Med 16, 821–844.
13. ↵
    1. Al Salloum AA,
    2. El Mouzan MI,
    3. Al Omar AA,
    4. Al Herbish AS,
    5. Qurashi MM

    (2011) The prevalence of neurological disorders in Saudi children:a community-based study. J Child Neurol 26, 21–24.
14. ↵
    1. Reid SM,
    2. Dagia CD,
    3. Ditchfield MR,
    4. Carlin JB,
    5. Reddihough DS

    (2014) Population-based studies of brain imaging patterns in cerebral palsy. Dev Med Child Neurol 56, 222–232.
15. ↵
    1. Monies D,
    2. Abouelhoda M,
    3. AlSayed M,
    4. Alhassnan Z,
    5. Alotaibi M,
    6. Kayyali H,
    7. et al.

    (2017) The landscape of genetic diseases in Saudi Arabia based on the first 1000 diagnostic panels and exomes. Hum Genet 136, 921–939.
16. ↵
    1. de Souza PVS,
    2. de Rezende Pinto WBV,
    3. de Rezende Batistella GN,
    4. Bortholin T,
    5. Oliveira ASB

    (2017) Hereditary Spastic Paraplegia:Clinical and Genetic Hallmarks. Cerebellum 16, 525–551.
17. ↵
    1. Thabet F,
    2. Tlili-Graiess K,
    3. Tabarki B

    (2019) Distinct neuroimaging features of DDHD2 gene-related spastic paraplegia, a mimicker of cerebral palsy. Arch Dis Child.
18. ↵
    1. Bi D,
    2. Wang H,
    3. Shang Q,
    4. Xu Y,
    5. Wang F,
    6. Chen M,
    7. et al.

    (2016) Association of COL4A1 gene polymorphisms with cerebral palsy in a Chinese Han population. Clin Genet 90, 149–155.
19. ↵
    1. Wolf B

    (2015) Biotinidase deficiency should be considered in individuals exhibiting myelopathy with or without and vision loss. Mol Genet Metab 116, 113–118.
20. ↵
    1. Jichlinski A,
    2. Clarke L,
    3. Whitehead MT,
    4. Gropman A

    (2018) “Cerebral Palsy” in a Patient With Arginase Deficiency. Semin Pediatr Neurol 26, 110–114.
21. ↵
    1. Al Mutairi F,
    2. Alfadhel M,
    3. Nashabat M,
    4. El-Hattab AW,
    5. Ben-Omran T,
    6. Hertecant J,
    7. et al.

    (2018) Phenotypic and Molecular Spectrum of Aicardi-Goutières Syndrome:A Study of 24 Patients. Pediatr Neurol 78, 35–40.
22. 1. Bosley TM,
    2. Alorainy IA,
    3. Oystreck DT,
    4. Hellani AM,
    5. Seidahmed MZ,
    6. Osman Mel F,
    7. et al.

    (2014) Neurologic injury in isolated sulfite oxidase deficiency. Can J Neurol Sci 41, 42–48.
23. 1. Van Rappard DF,
    2. Boelens JJ,
    3. Wolf NI

    (2015) Metachromatic leukodystrophy:Disease spectrum and approaches for treatment. Best Pract Res Clin Endocrinol Metab 29, 261–273.
24. 1. Wiesinger C,
    2. Eichler FS,
    3. Berger J

    (2015) The genetic landscape of X-linked adrenoleukodystrophy:inheritance, mutations, modifier genes, and diagnosis. Appl Clin Genet 8, 109–121.
25. ↵
    1. Cho KH,
    2. Shim SH,
    3. Kim M

    (2018) Clinical, biochemical, and genetic aspects of Sjögren-Larsson syndrome. Clin Genet 93, 721–730.
26. ↵
    1. Kulshreshtha D,
    2. Maurya PK,
    3. Singh AK,
    4. Thacker AK

    (2017) Dopa-responsive Dystonia in a Child Misdiagnosed as Cerebral Palsy. J Pediatr Neurosci 12, 172–173.
27. ↵
    1. Friedman J,
    2. Roze E,
    3. Abdenur JE,
    4. Chang R,
    5. Gasperini S,
    6. Saletti V,
    7. et al.

    (2012) Sepiapterin reductase deficiency:a treatable mimic of cerebral palsy. Ann Neurol 71, 520–530.
28. ↵
    1. AlSubhi S,
    2. AlShahwan S,
    3. AlMuhaizae M,
    4. AlZaidan H,
    5. Tabarki B

    (2017) Sepiapterin reductase deficiency:Report of 5 new cases. Eur J Paediatr Neurol 21, 583–586.
29. ↵
    1. Boy N,
    2. Mühlhausen C,
    3. Maier EM,
    4. Heringer J,
    5. Assmann B,
    6. Burgard P,
    7. et al.

    (2017) Proposed recommendations for diagnosing and managing individuals with glutaric aciduria type I:second revision. J Inherit Metab Dis 40, 75–101.
30. ↵
    1. Fons C,
    2. Campistol J

    (2016) Creatine Defects and Central Nervous System. Semin Pediatr Neurol 23, 285–289.
31. ↵
    1. Molero-Luis M,
    2. Serrano M,
    3. O'Callaghan MM,
    4. Sierra C,
    5. Pérez-Dueñas B,
    6. García-Cazorla A,
    7. et al.

    (2015) Clinical, etiological and therapeutic aspects of cerebral folate deficiency. Expert Rev Neurother 15, 793–802.
32. ↵
    1. Fu R,
    2. Chen CJ,
    3. Jinnah HA

    (2014) Genotypic and phenotypic spectrum in attenuated variants of Lesch-Nyhan disease. Mol Genet Metab 112, 280–285.
33. ↵
    1. Chang FC,
    2. Westenberger A,
    3. Dale RC,
    4. Smith M,
    5. Pall HS,
    6. Perez-Dueñas B,
    7. et al.

    (2016) Phenotypic insights into ADCY5-associated disease. Mov Disord 31, 1033–1040.
34. 1. Suzuki-Muromoto S,
    2. Wakusawa K,
    3. Miyabayashi T,
    4. Sato R,
    5. Okubo Y,
    6. Endo W,
    7. et al.

    (2018) A case of new PCDH12 gene variants presented as dyskinetic cerebral palsy with epilepsy. J Hum Genet 63, 749–753.
35. 1. McMichael G,
    2. Haan E,
    3. Gardner A,
    4. Yap TY,
    5. Thompson S,
    6. Ouvrier R,
    7. et al.

    (2013) NKX2-1 mutation in a family diagnosed with ataxic dyskinetic cerebral palsy. Eur J Med Genet 56, 506–509.
36. ↵
    1. Pacheva IH,
    2. Todorov T,
    3. Ivanov I,
    4. Tartova D,
    5. Gaberova K,
    6. Todorova A,
    7. et al.

    (2018) TSEN54 Gene-Related Pontocerebellar Hypoplasia Type 2 Could Mimic Dyskinetic Cerebral Palsy with Severe Psychomotor Retardation. Front Pediatr 6, 1.
37. ↵
    1. Méneret A,
    2. Roze E

    (2019) GLUT1 Deficiency in a Patient Diagnosed as Cerebral Palsy:Is NGS a Valuable Tool to Be Considered in All Cases of CP to Detect Underlying Genetic Disorders? Mov Disord Clin Pract 6, 277–279.
38. ↵
    1. Rothblum-Oviatt C,
    2. Wright J,
    3. Lefton-Greif MA,
    4. McGrath-Morrow SA,
    5. Crawford TO,
    6. Lederman HM

    (2016) Ataxia telangiectasia:a review. Orphanet J Rare Dis 11, 159.
39. ↵
    1. Chen YC,
    2. Liang WC,
    3. Su YN,
    4. Jong YJ

    (2014) Pelizaeus-Merzbacher disease, easily misdiagnosed as cerebral palsy:a report of a three-generation family. Pediatr Neonatol 55, 150–153.
40. ↵
    1. Sullivan R,
    2. Yau WY,
    3. O'Connor E,
    4. Houlden H

    (2019) Spinocerebellar ataxia:an update. J Neurol 266, 533–544.
41. ↵
    1. Kumar S,
    2. Singh D

    (2016) Joubert Syndrome Mimicking Hypotonic Cerebral Palsy. Indian J Pediatr 83, 1505.
42. ↵
    1. El-Hattab AW,
    2. Scaglia F

    (2016) Mitochondrial cytopathies. Cell Calcium 60, 199–206.
43. 1. Vafaee A,
    2. Baghdadi T,
    3. Norouzzadeh S

    (2018) Cockayne Syndrome Misdiagnosed as Cerebral Palsy. Iran J Child Neurol 12, 162–168.
44. 1. Suzuki R,
    2. Tanaka A,
    3. Matsui T,
    4. Gunji T,
    5. Tohyama J,
    6. Nairita A,
    7. et al.

    (2015) Niemann-Pick Disease Type C Presenting as a Developmental Coordination Disorder with Bullying by Peers in a School-Age Child. Case Rep Pediatr 2015, 807591.
45. ↵
    1. Regier DS,
    2. Proia RL,
    3. D'Azzo A,
    4. Tifft CJ

    (2016) The GM1 and GM2 Gangliosidoses:Natural History and Progress toward Therapy. Pediatr Endocrinol Rev 13, 663–673.
46. ↵
    1. McMillan HJ,
    2. Holahan AL,
    3. Richer J

    (2018) Worster-Drought Syndrome Associated With LINS Mutations. Child Neurol Open 5, 2329048X1879108.